Zhong-Ming Qian
Affiliations: | Hong Kong Polytechnic University (Hong Kong) |
Area:
Animal Physiology Biology, Neuroscience BiologyGoogle:
"Zhong-Ming Qian"Mean distance: 106866
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Jiang LR, Shen MQ, Bao YX, et al. (2022) Verapamil downregulates iron uptake and upregulates divalent metal transporter 1 expression in H9C2 cardiomyocytes. Fundamental & Clinical Pharmacology |
| Yang G, Qian C, Zhang C, et al. (2020) Hepcidin attenuates the iron-mediated secondary neuronal injury after intracerebral hemorrhage in rats. Translational Research : the Journal of Laboratory and Clinical Medicine |
| Liang T, Qian ZM, Mu MD, et al. (2020) Brain Hepcidin Suppresses Major Pathologies in Experimental Parkinsonism. Iscience. 23: 101284 |
| Li S, Qian ZM, Xu G, et al. (2020) Hepatocyte growth factor protects PC12 cells against OGD/R-induced injury by reducing iron. Bioscience Reports |
| Zhou YF, Wu XM, Zhou G, et al. (2017) Cystathionine β-synthase is required for body iron homeostasis. Hepatology (Baltimore, Md.) |
| Zhou YF, Zhang C, Yang G, et al. (2017) Hepcidin Protects Neuron from Hemin-Mediated Injury by Reducing Iron. Frontiers in Physiology. 8: 332 |
| Yu SS, Jiang LR, Ling Y, et al. (2017) Nifedipine Increases Iron Content in WKPT-0293 Cl.2 Cells via Up-Regulating Iron Influx Proteins. Frontiers in Pharmacology. 8: 60 |
| Zhang YT, Li FM, Guo YZ, et al. (2016) (Z)-ligustilide increases ferroportin1 expression and ferritin content in ischemic SH-SY5Y cells. European Journal of Pharmacology |
| Luo QQ, Qian ZM, Zhou YF, et al. (2016) Expression of Iron Regulatory Protein 1 Is Regulated not only by HIF-1 but also pCREB under Hypoxia. International Journal of Biological Sciences. 12: 1191-1202 |
| Wu XM, Qian ZM, Zhu L, et al. (2011) Neuroprotective effect of ligustilide against ischaemia-reperfusion injury via up-regulation of erythropoietin and down-regulation of RTP801. British Journal of Pharmacology. 164: 332-43 |